湿性伤口敷料市场－全球产业规模、份额、趋势、机会及预测：按产品、应用、最终用户、地区和竞争对手划分，2021-2031年

全球湿性伤口敷料市场预计将从 2025 年的 57.5 亿美元成长到 2031 年的 91.9 亿美元，复合年增长率为 8.13%。

与传统干纱布不同，这些专用医疗用品可透过维持湿润环境来促进组织修復并防止干燥。市场成长的主要驱动力是全球慢性疾病负担的加重，尤其是血管疾病和糖尿病，这些疾病导致需要高级护理的复杂溃疡病例不断增加。此外，全球老年人口的增长和外科手术数量的增加也推动了对有效术后伤口管理解决方案的需求，旨在最大限度地缩短恢復时间。

然而，这些先进的治疗方法价格昂贵，在预算紧张的医疗体系中往往面临严格的报销政策，阻碍了其广泛应用。儘管患者对慢性伤口管理的需求日益增长，但这项经济障碍仍然是一项巨大的挑战。国际糖尿病联盟（IDF）估计，到2024年，全球将有约5.89亿成年人患有糖尿病，凸显了开发经济有效的创伤护理策略以应对糖尿病足溃疡及其併发症日益增多的迫切需求。

市场驱动因素

慢性伤口和难癒合伤口（尤其是糖尿病足溃疡）的日益普遍，是全球湿性伤口敷料市场的主要驱动因素。这些复杂的伤口需要长期控制渗出液并维持湿润环境以促进上皮化，因此，使用亲水胶体和泡棉敷料等先进敷料而非传统纱布至关重要。慢性疾病的负担进一步凸显了这个临床需求。根据美国国立卫生研究院 (NIH) 2025 年 7 月发布的报告《人类伤口及其负担：2025 年估计值》，美国约有 1,050 万名联邦医疗保险受益人患有慢性伤口，这造成了对治疗方案的巨大需求。

同时，全球老年人口的快速成长正显着影响市场需求。老年患者的生理变化会延缓伤口癒合，与老龄化相关的皮肤血管减少也会增加压疮的风险。世界卫生组织（世卫组织）于2025年2月发布的最新报告《老化与健康》指出，2024年全球平均寿命将达到73.3岁，将推动人口结构的变化，预计2030年，60岁以上人口将达到14亿。这项需求也反映在产业绩效上。康维特集团在2025年2月发布的《截至2024年12月31日止年度财务业绩》中报告称，其创伤护理部门的有机收入增长了7.4%，这主要得益于抗菌和泡沫技术的进步。

市场挑战

全球湿性伤口敷料市场成长的主要障碍在于先进治疗方法的高成本以及预算紧张的医疗体系中严格的报销政策。儘管湿性伤口敷料相比传统干纱布具有更优的临床疗效，但其高昂的价格在註重成本的市场中却构成了一大障碍。医疗机构和保险公司往往在没有充分的财务理由的情况下，不愿意核准使用如此昂贵的医疗用品，导致人们必须依赖更便宜但疗效较差的替代方案。这种财务上的阻碍限制了先进产品的普及，尤其是在严格财务监管的公共医疗领域。

因此，治疗慢性疾病的经济负担反而限制了针对慢性疾病管理的解决方案的普及。根据创伤治疗）预测，到2025年，慢性伤口的管理预计将每年耗费美国联邦医疗保险（Medicare）约225亿美元。如此巨大的经济负担迫使支付方采用严格的报销标准，这反过来又阻碍了高价湿敷料技术的市场渗透，并减缓了整个行业的扩张。

市场趋势

市场正经历着一场决定性的转变，即转向具有生物活性和抗菌特性的混合敷料，这类敷料能够主动促进组织修復，而不仅仅提供被动的屏障功能。这项转变的驱动力源自于临床上解决复杂慢性溃疡生物膜形成和癒合停滞问题的需求，促使製造商将生物细胞结构和银技术等活化剂直接融入敷料基质中。对这些高效治疗方案的需求正在显着改变产业的收入结构。根据史密斯医疗（Smith+Nephew）于2025年2月发布的“2024财年第四季度及全年业绩报告”，其高级伤口生物活性产品业务部门实现了20.3%的基础收入增长，这主要得益于皮肤替代物和感染控制产品的强劲市场需求。

同时，随着主要相关人员将业务活动与环境管治相结合，努力减少医疗废弃物，人们对可生物降解和永续的创伤护理解决方案的兴趣日益浓厚。这一趋势正迫使企业重新设计其製造生态系统，优先考虑在地化生产和可再生能源的整合，以降低高能耗泡沫和硅胶材料生产过程中的碳排放强度。例如，根据2025年6月一篇题为《Mornlycke Healthcare 为提升永续製造能力而进行史上最大规模投资，并在美国缅因州扩建工厂》的报导，该公司宣布投资1.15亿欧元，利用风能和太阳能等再生能源来源扩建其製造工厂，这便是向可持续基础设施战略转变的一个例证。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球湿性伤口敷料市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 产品类别（泡棉敷料、亲水胶体敷料、膜敷料、藻酸盐敷料、水凝胶敷料、胶原蛋白敷料、其他）
  • 依应用领域（急性伤口、慢性伤口）
  • 依最终使用者（医院、专科诊所、居家医疗等）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美湿性伤口敷料市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲湿敷料市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区湿性伤口敷料市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲湿性伤口敷料市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲湿敷料市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章 全球湿性伤口敷料市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Coloplast A/S
• Medline Industries, Inc.
• Smith & Nephew PLC
• Convatec, Inc.
• Systagenix pvt ltd
• Derma Sciences, Inc.
• Cardinal Health Inc.
• Acelity LPInc
• 3M Company
• B. Braun Medical Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Moist Wound Dressings Market is projected to expand from USD 5.75 Billion in 2025 to USD 9.19 Billion by 2031, registering a CAGR of 8.13%. Unlike traditional dry gauze, these specialized medical supplies maintain a hydrated environment to accelerate tissue repair and prevent desiccation. The market is fundamentally driven by the rising global burden of chronic diseases, specifically vascular disorders and diabetes, which result in a higher incidence of complex ulcers necessitating advanced care. Furthermore, the expanding geriatric population and increasing volume of surgical procedures worldwide sustain the demand for effective postoperative wound management solutions aimed at minimizing recovery times.

However, widespread adoption is hindered by the high costs associated with these advanced therapies, which frequently encounter strict reimbursement policies within budget-constrained healthcare systems. Despite the escalating patient need for chronic wound management, this financial hurdle remains a significant obstacle. According to the International Diabetes Federation, an estimated 589 million adults worldwide were living with diabetes in 2024, underscoring the critical necessity for cost-effective wound care strategies to manage the associated rise in diabetic foot ulcers and complications.

Market Driver

The escalating prevalence of chronic and non-healing wounds, particularly diabetic foot ulcers, serves as the primary catalyst for the global moist wound dressings market. These complex wounds require prolonged exudate management and moisture balance to facilitate re-epithelialization, necessitating advanced dressings like hydrocolloids and foams rather than traditional gauze. This clinical necessity is underscored by the burden of chronic conditions; according to the National Institutes of Health's 'Human Wound and Its Burden: Updated 2025 Compendium of Estimates,' published in July 2025, chronic wounds affect approximately 10.5 million Medicare beneficiaries in the United States, creating substantial demand for therapeutic solutions.

Simultaneously, the rapid expansion of the global geriatric population critically shapes market demand, as physiological changes in elderly patients delay healing and aging skin's reduced vascularity increases susceptibility to pressure ulcers. According to the World Health Organization's 'Ageing and Health' update from February 2025, global life expectancy reached 73.3 years in 2024, driving a demographic shift where the population aged 60 and older is projected to reach 1.4 billion by 2030. This demand is reflected in industry performance; Convatec Group Plc reported in their 'Annual Results for the year ended 31 December 2024,' released in February 2025, that their Advanced Wound Care division achieved organic revenue growth of 7.4%, driven by antimicrobial and foam technologies.

Market Challenge

The primary factor hampering the growth of the Global Moist Wound Dressings Market is the high cost of advanced therapies coupled with strict reimbursement policies in budget-constrained healthcare systems. While moist wound dressings offer superior clinical outcomes compared to traditional dry gauze, their premium pricing creates a substantial barrier in markets where cost containment is a priority. Healthcare providers and insurers often hesitate to authorize these expensive supplies without irrefutable economic justification, leading to a reliance on cheaper, less effective alternatives. This financial friction limits the volume of advanced products utilized, particularly in public health sectors facing tight fiscal scrutiny.

Consequently, the economic burden of treating chronic conditions paradoxically restricts the adoption of the very solutions designed to manage them. According to the Wound Healing Society, in 2025, the management of chronic wounds cost the Medicare system an estimated 22.5 billion dollars annually. This immense financial strain compels payers to enforce rigorous reimbursement criteria, thereby reducing the market penetration of higher-priced moist dressing technologies and slowing overall industry expansion.

Market Trends

The market is witnessing a decisive shift toward bioactive and antimicrobial hybrid dressings that actively stimulate tissue repair rather than merely serving as a passive barrier. This transition is fueled by the clinical necessity to combat biofilm formation and stalled healing trajectories in complex chronic ulcers, prompting manufacturers to integrate active agents, such as living cell constructs and silver technologies, directly into dressing matrices. This demand for high-efficacy therapeutic solutions is significantly reshaping industry revenue streams; according to Smith+Nephew's 'Fourth Quarter and Full Year 2024 Results' from February 2025, the Advanced Wound Bioactives business unit delivered underlying revenue growth of 20.3%, driven by the strong adoption of skin substitutes and infection management products.

Concurrently, there is an intensifying focus on biodegradable and sustainable wound care solutions as major stakeholders align operational footprints with environmental governance to mitigate medical waste. This trend compels companies to redesign manufacturing ecosystems, prioritizing localized production and renewable energy integration to lower the carbon intensity of producing energy-intensive foam and silicone materials. Highlighting this strategic pivot toward sustainable infrastructure, according to the article 'Molnlycke Health Care makes record investment to increase global manufacturing capacity with expansion in Maine, USA' from June 2025, Molnlycke Health Care announced a €115 million investment to expand a manufacturing facility designed to utilize renewable energy sources such as wind and solar power.

Key Market Players

• Coloplast A/S
• Medline Industries, Inc.
• Smith & Nephew PLC
• Convatec, Inc.
• Systagenix pvt ltd
• Derma Sciences, Inc.
• Cardinal Health Inc.
• Acelity L.P.Inc
• 3M Company
• B. Braun Medical Inc.

Report Scope

In this report, the Global Moist Wound Dressings Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Moist Wound Dressings Market, By Product

• Foam Dressings
• Hydrocolloid Dressings
• Film Dressings
• Alginate Dressings
• Hydrogel Dressings
• Collagen Dressings
• Other

Moist Wound Dressings Market, By Application

• Acute Wounds
• Chronic Wounds

Moist Wound Dressings Market, By End User

• Hospitals
• Specialty Clinics
• Home Healthcare
• Others

Moist Wound Dressings Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Moist Wound Dressings Market.

Available Customizations:

Global Moist Wound Dressings Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Moist Wound Dressings Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Foam Dressings, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings, Collagen Dressings, Other)
  • 5.2.2. By Application (Acute Wounds, Chronic Wounds)
  • 5.2.3. By End User (Hospitals, Specialty Clinics, Home Healthcare, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Moist Wound Dressings Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Moist Wound Dressings Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Moist Wound Dressings Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Moist Wound Dressings Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Moist Wound Dressings Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Moist Wound Dressings Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Moist Wound Dressings Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Moist Wound Dressings Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Moist Wound Dressings Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Moist Wound Dressings Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Moist Wound Dressings Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Moist Wound Dressings Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Moist Wound Dressings Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Moist Wound Dressings Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Moist Wound Dressings Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Moist Wound Dressings Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Moist Wound Dressings Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Moist Wound Dressings Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Moist Wound Dressings Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Moist Wound Dressings Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Moist Wound Dressings Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Moist Wound Dressings Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Moist Wound Dressings Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Moist Wound Dressings Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Moist Wound Dressings Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Coloplast A/S
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Medline Industries, Inc.
• 15.3. Smith & Nephew PLC
• 15.4. Convatec, Inc.
• 15.5. Systagenix pvt ltd
• 15.6. Derma Sciences, Inc.
• 15.7. Cardinal Health Inc.
• 15.8. Acelity L.P.Inc
• 15.9. 3M Company
• 15.10. B. Braun Medical Inc.

16. Strategic Recommendations

17. About Us & Disclaimer